Division of Health Services Administration, Department of Preventive Medicine and Biostatistics, F. Edward Hebert School of Medicine, The Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD, 20814, USA.
Department of Health, Society, and Behavior, University of California, Irvine, CA, USA.
BMC Womens Health. 2024 Mar 25;24(1):196. doi: 10.1186/s12905-024-03019-w.
The rates of suicide and opioid use disorder (OUD) among pregnant and postpartum women continue to increase. This research characterized OUD and suicide attempts among Medicaid-enrolled perinatal women and examined prenatal OUD diagnosis as a marker for postpartum suicide attempts.
Data from Oregon birth certificates, Medicaid eligibility and claims files, and hospital discharge records were linked and analyzed. The sample included Oregon Medicaid women aged 15-44 who became pregnant and gave live births between January 2008 and January 2016 (N = 61,481). Key measures included indicators of suicide attempts (separately for any means and opioid poisoning) and OUD diagnosis, separately assessed during pregnancy and the one-year postpartum period. Probit regression was used to examine the overall relationship between prenatal OUD diagnosis and postpartum suicide attempts. A simultaneous equations model was employed to explore the link between prenatal OUD diagnosis and postpartum suicide attempts, mediated by postpartum OUD diagnosis.
Thirty-three prenatal suicide attempts by any means were identified. Postpartum suicide attempts were more frequent with 58 attempts, corresponding to a rate of 94.3 attempts per 100,000. Of these attempts, 79% (46 attempts) involved opioid poisoning. A total of 1,799 unique women (4.6% of the sample) were diagnosed with OUD either during pregnancy or one-year postpartum with 53% receiving the diagnosis postpartum. Postpartum suicide attempts by opioid poisoning increased from 55.5 per 100,000 in 2009 to 105.1 per 100,000 in 2016. The rate of prenatal OUD also almost doubled over the same period. Prenatal OUD diagnosis was associated with a 0.15%-point increase in the probability of suicide attempts by opioid poisoning within the first year postpartum. This increase reflects a three-fold increase compared to the rate for women without a prenatal OUD diagnosis. A prenatal OUD diagnosis was significantly associated with an elevated risk of postpartum suicide attempts by opioid poisoning via a postpartum OUD diagnosis.
The risk of suicide attempt by opioid poisoning is elevated for Medicaid-enrolled reproductive-age women during pregnancy and postpartum. Women diagnosed with prenatal OUD may face an increased risk of postpartum suicides attempts involving opioid poisoning.
孕妇和产后妇女的自杀率和阿片类药物使用障碍(OUD)继续上升。本研究描述了参加医疗补助计划的围产期妇女中的 OUD 和自杀企图,并研究了产前 OUD 诊断是否是产后自杀企图的标志。
将俄勒冈州出生证明、医疗补助资格和索赔文件以及医院出院记录进行了链接和分析。样本包括 2008 年 1 月至 2016 年 1 月期间怀孕并分娩的俄勒冈州 15-44 岁的医疗补助女性(N=61481)。关键指标包括自杀企图指标(分别为任何手段和阿片类药物中毒)和 OUD 诊断,分别在怀孕期间和产后一年进行评估。采用概率回归分析产前 OUD 诊断与产后自杀企图之间的总体关系。采用联立方程模型探讨产前 OUD 诊断与产后自杀企图之间的关系,通过产后 OUD 诊断来介导。
共确定了 33 例产前任何手段自杀企图。产后自杀企图更常见,有 58 例自杀企图,每 100,000 人中有 94.3 例。其中,79%(46 例)涉及阿片类药物中毒。共有 1799 名女性(占样本的 4.6%)在怀孕期间或产后一年被诊断出患有 OUD,其中 53%在产后被诊断出。2009 年,阿片类药物中毒引起的产后自杀企图率为每 100,000 人 55.5 例,2016 年增至每 100,000 人 105.1 例。同期,产前 OUD 的发生率几乎翻了一番。产前 OUD 诊断与产后第一年阿片类药物中毒自杀企图的可能性增加 0.15%。与没有产前 OUD 诊断的女性相比,这一增长反映了三倍的增长。产前 OUD 诊断与产后 OUD 诊断后发生阿片类药物中毒导致的产后自杀企图风险显著相关。
在怀孕和产后期间,参加医疗补助计划的育龄妇女因阿片类药物中毒导致自杀企图的风险增加。被诊断患有产前 OUD 的女性可能面临涉及阿片类药物中毒的产后自杀企图的风险增加。